Lumos Diagnostics Holdings Ltd. (LDXHF) Stock Statistics & Valuation Metrics

Lumos Diagnostics Holdings Ltd. has a market cap or net worth of $41.69M. The enterprise value is $85.46M.

Market Cap

$41.69M

Enterprise Value

$85.46M

Lumos Diagnostics Holdings Ltd. has 988,166,260 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

988,166,260

Owned by Insiders

1.61%

Owned by Institutions

<0.01%

Lumos Diagnostics Holdings Ltd.’s return on equity (ROE) is -0.22 and return on invested capital (ROIC) is -45.56%.

Return on Equity (ROE)

-0.22

Return on Assets (ROA)

-0.12

Return on Invested Capital (ROIC)

-45.56%

Return on Capital Employed (ROCE)

-0.52

Revenue Per Employee

―

Profits Per Employee

―

Employee Count

―

Asset Turnover

0.33

Inventory Turnover

13.04

The current PE Ratio of Lumos Diagnostics Holdings Ltd. is -6.41. Lumos Diagnostics Holdings Ltd.’s PEG ratio is -0.30.

PE Ratio

-6.41

PS Ratio

3.12

PB Ratio

1.72

Price to FCF

-26.99

Price to Operating Cash Flow

40.53

PEG Ratio

-0.30

In the last 12 months, Lumos Diagnostics Holdings Ltd. had revenue of 13.48M and earned -5.06M in profits. Earnings per share was -0.01.

Revenue

13.48M

Gross Profit

-7.91M

Operating Income

-14.44M

Pretax Income

-5.57M

Net Income

-5.06M

EBITDA

-11.84M

Earnings Per Share (EPS)

-0.01

In the last 12 months, operating cash flow was 970.13K and capital expenditures -2.49M, giving a free cash flow of -1.52M billion.

Operating Cash Flow

970.13K

Free Cash Flow

-1.52M

Free Cash Flow per Share

-0.00

Lumos Diagnostics Holdings Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share

―

Dividend Yield

―

Payout Ratio

N/A

Free Cash Flow Yield

-3.87%

Earnings Yield

-13.38%

Beta

2.55

52-Week Price Change

-65.99%

50-Day Moving Average

0.07

200-Day Moving Average

0.11

Relative Strength Index (RSI)

31.15

Average Volume (3m)

32.23K

Lumos Diagnostics Holdings Ltd. upcoming earnings date is Mar 04, 2027, TBA (Not Confirmed).

Last Earnings Date

Aug 25, 2026

Next Earnings Date

Mar 04, 2027

Ex-Dividend Date

―

Lumos Diagnostics Holdings Ltd. as a current ratio of 1.52, with Debt / Equity ratio of 25.98%

Current Ratio

1.52

Quick Ratio

1.40

Debt to Market Cap

0.02

Net Debt to EBITDA

0.80

Interest Coverage Ratio

-6.90

In the past 12 months, Lumos Diagnostics Holdings Ltd. has paid -510.98K in taxes.

Income Tax

-510.98K

Effective Tax Rate

0.09

Lumos Diagnostics Holdings Ltd. EV to EBITDA ratio is -2.58, with an EV/FCF ratio of -19.63.

EV to Sales

2.27

EV to EBITDA

-2.58

EV to Free Cash Flow

-19.63

EV to Operating Cash Flow

30.84

Lumos Diagnostics Holdings Ltd. has $15.42M in cash and marketable securities with $5.94M in debt, giving a net cash position of $9.48M billion.

Cash & Marketable Securities

$15.42M

Total Debt

$5.94M

Net Cash

$9.48M

Net Cash Per Share

$0.01

Tangible Book Value Per Share

$0.01

Gross margin is -58.54%, with operating margin of -107.10%, and net profit margin of -38.18%.

Gross Margin

-58.54%

Operating Margin

-107.10%

Pretax Margin

-38.18%

Net Profit Margin

-38.18%

EBITDA Margin

-87.78%

EBIT Margin

-107.10%

The average price target for Lumos Diagnostics Holdings Ltd. is $0.14, which is 11.43% higher than the current price. The consensus rating is Moderate Buy

Price Target

$0.14

Price Target Upside

182.42% Upside

Analyst Consensus

Moderate Buy

Analyst Count

1

Revenue Growth Forecast

6.39%

EPS Growth Forecast

38.46%

Smart Score

6

AI Score

―